Download the presentations from our live event in Cambridge, MA. Industry leaders discussed transformative research with implications for drug discovery and clinical practice 
across the field of immuno-oncology. They shared how their research is breaking down the barriers to novel oncology treatment options.
Speakers from various organizations included:
- Parul Agnihotri, PhD, Genocea Biosciences. presented ATLAS™ Technology Improves Neoantigen Selection
for Personalized Cancer Vaccines - Lorella Di Donato, PhD, Caprion Biosciences, presented A GCLP Workflow for the Measurement of Protein Biomarkers in FFPE Tissue Samples by Mass Spectrometry
- Johanna K. Kaufmann, PhD, TESARO a GSK Company, presented Beyond PD-1 Blockade: Combination Immune Checkpoint Inhibition Engages Multiple Mechanisms of Action
- Shashi Murthy, PhD, Flaskworks, presented Innovative Approaches for Neoantigen-Based T Cell Therapy Manufacturing
- Julia Schüler, PhD, DVM, Charles River Laboratories, presented PDX Models of Solid Cancer Express Distinct Cytokine Profiles Relating to Their Tumor Infiltrating Lymphocyte Landscape
- Russel Weiner, PhD, the Bill & Melinda Gates Medical Research Institute, presented Successful Implementation of Global Biomarker Strategies: Pre-Analytics Matters (But is Often Ignored)